avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mef2d
|
ENSMUSG00000001419.11 | myocyte enhancer factor 2D |
Mef2a
|
ENSMUSG00000030557.10 | myocyte enhancer factor 2A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mef2d | mm10_v2_chr3_+_88142328_88142483 | 0.21 | 2.1e-01 | Click! |
Mef2a | mm10_v2_chr7_-_67372846_67372858 | 0.10 | 5.5e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 19.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.8 | 8.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
2.5 | 7.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.4 | 23.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.1 | 14.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.0 | 6.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
1.8 | 8.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.8 | 15.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 8.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
1.2 | 6.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.9 | 41.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 5.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 4.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.8 | 2.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.8 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 5.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 8.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 1.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.6 | 5.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.6 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 4.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.6 | 1.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 1.7 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.5 | 5.4 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.5 | 2.4 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.5 | 4.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 6.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 34.0 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 0.9 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.4 | 2.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 3.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 56.9 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.3 | 1.2 | GO:2000292 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.3 | 0.9 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 2.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 4.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.6 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 4.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.2 | 6.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 4.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 2.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 9.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.7 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 10.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.4 | GO:1904937 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.1 | 1.6 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 1.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.3 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.1 | 0.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.1 | 1.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 2.5 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 4.7 | GO:0003012 | muscle system process(GO:0003012) |
0.0 | 2.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 1.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.9 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.0 | 1.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 1.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.0 | 2.5 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 0.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.7 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 1.2 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 3.5 | GO:0006470 | protein dephosphorylation(GO:0006470) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 14.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
2.8 | 8.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.8 | 19.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.5 | 22.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.9 | 33.3 | GO:0005861 | troponin complex(GO:0005861) |
1.5 | 39.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.3 | 13.4 | GO:0032982 | myosin filament(GO:0032982) |
1.2 | 7.3 | GO:0031673 | H zone(GO:0031673) |
0.9 | 8.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 5.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 5.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 1.5 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.5 | 10.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 33.6 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 1.8 | GO:0090537 | CERF complex(GO:0090537) |
0.4 | 65.9 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 5.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 5.7 | GO:0031674 | I band(GO:0031674) |
0.3 | 5.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.8 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 6.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 3.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 4.5 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.6 | GO:0036379 | myofilament(GO:0036379) |
0.0 | 3.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 1.7 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 3.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 27.8 | GO:0051373 | FATZ binding(GO:0051373) |
2.2 | 22.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.9 | 50.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.8 | 15.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 9.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 5.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 8.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.7 | 5.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 1.8 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.5 | 1.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.5 | 6.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.5 | 2.4 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.5 | 2.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 5.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 1.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 18.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 0.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.3 | 4.9 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.0 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 4.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 5.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.8 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 5.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 4.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 7.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 2.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 1.3 | GO:1990239 | sodium:potassium-exchanging ATPase activity(GO:0005391) steroid hormone binding(GO:1990239) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 4.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 8.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 4.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 56.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 15.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 3.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 2.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 5.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 1.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 12.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 2.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 5.9 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 1.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 14.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 2.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.4 | PID CDC42 PATHWAY | CDC42 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 119.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 15.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 5.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 8.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 5.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 7.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 4.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 4.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 3.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 12.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |